Publicaciones en las que colabora con Javier Menárguez Palanca (11)

2003

  1. Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A

    Cancer Research, Vol. 63, Núm. 8, pp. 1814-1817

2002

  1. Genetic analysis of RET, GFrα1 and GDNF genes in Spanish families with multiple endocrine neoplasia type 2A

    International Journal of Cancer, Vol. 99, Núm. 2, pp. 299-304

2000

  1. Analysis of the cyclin D1/p16/pRb pathway in parathyroid adenomas

    Endocrine Pathology, Vol. 11, Núm. 3, pp. 259-266

  2. p53/MDM2 Pathway aberrations in parathyroid tumors: p21(WAF-1) and MDM2 are frequently overexpressed in parathyroid adenomas

    Endocrine Pathology, Vol. 11, Núm. 3, pp. 251-257

1999

  1. The vitamin D receptor gene polymorphism and parathyroid function [6]

    Nephrology Dialysis Transplantation

1998

  1. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina - Correlation with Epstein Barr virus presence

    Pathology Research and Practice, Vol. 194, Núm. 1, pp. 25-31

1997

  1. Absence of EBV genome in lymphoepithelioma-like carcinomas of the larynx

    Histopathology, Vol. 30, Núm. 2, pp. 126-128

  2. HIV-associated oral pleomorphic B-cell malignant lymphoma

    Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, Vol. 84, Núm. 2, pp. 142-145

1996

  1. Hepatosplenic γδ T-cell Lymphoma

    The American Journal of Surgical Pathology, Vol. 20, Núm. 5, pp. 641

  2. The determination of monoclonality in B-cell lymphomas using the polymerase chain reaction technic on paraffin-embedded material.

    Medicina clínica, Vol. 107, pp. 50-2.

1995

  1. Hepatosplenic gamma‐delta T‐cell malignant lymphoma: report of the first case in childhood, including molecular minimal residual disease follow‐up

    British Journal of Haematology, Vol. 90, Núm. 4, pp. 943-946